Tag Archive for: in vitro diagnostics

Brazil and Mexico Lead IVD Investments in Latin America

/0 Comments/by Daniel Granderson
Read more

China: Molecular Point-of-Care’s International Market to Watch

/by Daniel Granderson

Molecular point-of-care (mPOC) is a multi-billion dollar market with expanding international intrigue. Though the mPOC market is led by North America and Europe, the Asia-Pacific region makes up 10% of the market’s worldwide sales, with China positioned as a burgeoning power within the APAC. Kalorama Information, a leading medical market research firm, covers mPOC’s global […]

Read more

2023 Healthcare Trend: Growth in $21 Billion Molecular Diagnostics Market

/by Daniel Granderson

Future molecular IVD sales buoyed by COVID-19, infectious diseases, and sexually transmitted infections There is a market in excess of $21 billion for molecular testing technologies, reveals medical market research publisher Kalorama Information in The World Market for Molecular Diagnostics Tests, 11th Edition, a recent report added to the firm’s Knowledge Center subscription.  The majority […]

Read more

COVID-19 and 6 Other Trends Impacting the In Vitro Diagnostics (IVD) Market

/by Daniel Granderson

  “In many ways, the IVD testing market is center stage for the fight against the coronavirus…The COVID-19 market continues to play a major role in the growth of the IVD market with tests for the virus representing 27% of sales in 2021.” – Kalorama Information   Make no mistake, the in vitro diagnostics (IVD) […]

Read more

Cancer IVD: 4 Trends to Watch in $5.5 Billion Market

/by Daniel Granderson

  Whether affecting the lungs, colorectal system, stomach, liver, breasts, or other parts of the body, few medical maladies carry the inherent gravitas of cancer. Annually, millions of new cancer cases are diagnosed and millions of cancer linked deaths occur worldwide.  Undoubtedly, cancer poses one of the greatest threats to human health globally. This proliferating […]

Read more

In Breaking Transmission Chain of COVID-19 and Other Diseases, Point-of-Care is Best Hope

/by Bruce Carlson

Demand for testing has gone from a healthcare industry topic to a national crusade in weeks with the onset of COVID-19. High-throughput tests have been approved by the U.S. Food and Drug Administration (FDA) for use in the U.S. for the detection of SARS-CoV-2, the virus behind the disease. But for true intervention in doctors […]

Read more

The World Market for Biomarkers

/by Bill Kelly

We have just published our latest report, The World Market for Biomarkers. Biomarkers are biological or biochemical molecules, genetic changes, or other characteristics that can be measured; they indicate or predict a condition, risk, or likely biological response. Biomarkers can be used for a range of diagnostic applications including predicting disease risk, diagnosis, predicting prognosis, […]

Read more